Skip to content
PubMed This is a summary of 71 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 71 referenced papers

References

References (71)
  1. 1

    IgG4-related ophthalmic disease. Part I: background and pathology.

    McNab AA, McKelvie P

    Ophthalmic plastic and reconstructive surgery 2015; (31(2)):83-8 doi:10.1097/IOP.0000000000000363.

    PMID: 25564257
  2. 2

    IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.

    McNab AA, McKelvie P

    Ophthalmic plastic and reconstructive surgery 2015; (31(3)):167-78 doi:10.1097/IOP.0000000000000364.

    PMID: 25564258
  3. 3

    Clinical and Imaging Features of Lacrimal Gland Involvement in Granulomatosis with Polyangiitis.

    Tan LT, Davagnanam I, Isa H, et al.

    Ophthalmology 2015; (122(10)):2125-9.

    PMID: 26233627
  4. 4

    The many facets of dacryoadenitis.

    Mombaerts I

    Current opinion in ophthalmology 2015; (26(5)):399-407 doi:10.1097/ICU.0000000000000183.

    PMID: 26247137
  5. 5

    Management of orbital IgG4-related disease.

    Glass LR, Freitag SK

    Current opinion in ophthalmology 2015; (26(6)):491-7 doi:10.1097/ICU.0000000000000204.

    PMID: 26367090
  6. 6

    Idiopathic Dacryoadenitis: Clinical Features, Histopathology, and Treatment Outcomes.

    Andrew NH, Kearney D, Sladden N, et al.

    American journal of ophthalmology 2016; (163()):148-153.e1 doi:10.1016/j.ajo.2015.11.032.

    PMID: 26701269
  7. 7

    Bilateral IgG4-related ophthalmic disease: a strong indication for systemic imaging.

    Wu A, Andrew NH, McNab AA, Selva D

    The British journal of ophthalmology 2016; (100(10)):1409-11 doi:10.1136/bjophthalmol-2015-307437.

    PMID: 26719494
  8. 8

    Orbital inflammation: Biopsy first.

    Mombaerts I, Rose GE, Garrity JA

    Survey of ophthalmology 2016; (61(5)):664-9.

    PMID: 26994870
  9. 9

    Relationship between dacryoadenitis subtype of idiopathic orbital inflammatory pseudotumor and paranasal sinusitis.

    Li J, Ge X, Ma JM

    International journal of ophthalmology 2016; (9(3)):444-7 doi:10.18240/ijo.2016.03.21.

    PMID: 27158618
  10. 10

    Orbital Involvement and Ocular Surface Changes in IgG4-Related Systemic Disease.

    Kocabeyoglu S, Karadag O, Mocan MC, et al.

    Cornea 2016; (35(11)):1449-1453 doi:10.1097/ICO.0000000000000965.

    PMID: 27467041
  11. 11

    Bilateral Dacryoadenitis: Don't Forget Tuberculosis!

    Ruman-Colombier M, Crisinel PA, Cohen-Dumani N, et al.

    The Pediatric infectious disease journal 2017; (36(1)):117-119 doi:10.1097/INF.0000000000001365.

    PMID: 27956729
  12. 12

    Granulomatosis with polyangiitis confined to lacrimal gland, a case report.

    Zuazo F, González M, Abdala A, et al.

    Archivos de la Sociedad Espanola de Oftalmologia 2017; (92(11)):543-546 doi:10.1016/j.oftal.2016.11.006.

    PMID: 28017483
  13. 13

    Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.

    Han J, Kim YD, Woo KI, Sobti D

    Ophthalmic plastic and reconstructive surgery 2018; (34(1)):74-78 doi:10.1097/IOP.0000000000000877.

    PMID: 28221296
  14. 14

    Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.

    Ebbo M, Patient M, Grados A, et al.

    Medicine 2017; (96(10)):e6205 doi:10.1097/MD.0000000000006205.

    PMID: 28272212
  15. 15

    Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach.

    Mombaerts I, Bilyk JR, Rose GE, et al.

    JAMA ophthalmology 2017; (135(7)):769-776 doi:10.1001/jamaophthalmol.2017.1581.

    PMID: 28570731
  16. 16

    Lacrimal gland development: From signaling interactions to regenerative medicine.

    Garg A, Zhang X

    Developmental dynamics : an official publication of the American Association of Anatomists 2017; (246(12)):970-980 doi:10.1002/dvdy.24551.

    PMID: 28710815
  17. 17

    Lacrimal gland abscesses: Case series and literature review.

    Savoie B, Rodgers R, Gorski M

    Orbit (Amsterdam, Netherlands) 2017; (36(6)):428-432 doi:10.1080/01676830.2017.1337205.

    PMID: 28812417
  18. 18

    The role of biopsy in lacrimal gland inflammation: A clinicopathologic study.

    Luemsamran P, Rootman J, White VA, et al.

    Orbit (Amsterdam, Netherlands) 2017; (36(6)):411-418 doi:10.1080/01676830.2017.1352608.

    PMID: 28816552
  19. 19

    Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.

    Rosenbaum JT, Choi D, Harrington CA, et al.

    JAMA ophthalmology 2017; (135(11)):1156-1162 doi:10.1001/jamaophthalmol.2017.3458.

    PMID: 28975236
  20. 20

    Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease.

    Hong JW, Kang S, Song MK, et al.

    The British journal of ophthalmology 2018; (102(11)):1591-1595 doi:10.1136/bjophthalmol-2017-311519.

    PMID: 29420193
  21. 21

    Immunoglobulin G4-related dacyroadenitis presenting as bilateral chorioretinal folds from severely enlarged lacrimal glands.

    Kurokawa T, Hamano H, Muraki T, et al.

    American journal of ophthalmology case reports 2018; (9()):88-92 doi:10.1016/j.ajoc.2018.01.017.

    PMID: 29468226
  22. 22

    Man with a Swollen Eye: Nonspecific Orbital Inflammation in an Adult in the Emergency Department.

    Zhang XC, Statler B, Suner S, et al.

    The Journal of emergency medicine 2018; (55(1)):110-113 doi:10.1016/j.jemermed.2018.04.001.

    PMID: 29716820
  23. 23

    Pleomorphic adenoma of the lacrimal gland: A review with updates on malignant transformation and molecular genetics.

    Harrison W, Pittman P, Cummings T

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2018; (32(1)):13-16 doi:10.1016/j.sjopt.2018.02.014.

    PMID: 29755265
  24. 24

    Grading Severity and Activity in Thyroid Eye Disease.

    Dolman PJ

    Ophthalmic plastic and reconstructive surgery 2018; (34(4S Suppl 1)):S34-S40 doi:10.1097/IOP.0000000000001150.

    PMID: 29952931
  25. 25

    Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand.

    Seresirikachorn K, Norasetthada L, Ausayakhun S, et al.

    Blood research 2018; (53(4)):307-313 doi:10.5045/br.2018.53.4.307.

    PMID: 30588468
  26. 26

    The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature.

    Detiger SE, Karim AF, Verdijk RM, et al.

    Acta ophthalmologica 2019; (97(5)):451-459 doi:10.1111/aos.14048.

    PMID: 30734497
  27. 27

    Clinicopathologic features of biopsied lacrimal gland masses in 95 Korean patients.

    Ahn C, Kang S, Sa HS

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2019; (257(7)):1527-1533 doi:10.1007/s00417-019-04327-w.

    PMID: 31025214
  28. 28

    Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation.

    Eshraghi B, Sonbolestan SA, Abtahi MA, Mirmohammadsadeghi A

    Journal of current ophthalmology 2019; (31(3)):327-334 doi:10.1016/j.joco.2019.03.004.

    PMID: 31528770
  29. 29

    Tuberculosis presenting as dacryoadenitis in the USA.

    Powers HR, Diaz MA, Mendez JC

    BMJ case reports 2019; (12(11)) doi:10.1136/bcr-2019-231694.

    PMID: 31748361
  30. 30

    Lymphoma of the Lacrimal Gland - An International Multicenter Retrospective Study.

    Vest SD, Mikkelsen LH, Holm F, et al.

    American journal of ophthalmology 2020; (219()):107-120 doi:10.1016/j.ajo.2020.06.015.

    PMID: 32574779
  31. 31

    Acute dacryoadenitis in a patient with SARS-CoV-2 infection.

    Martínez Díaz M, Copete Piqueras S, Blanco Marchite C, Vahdani K

    Orbit (Amsterdam, Netherlands) 2022; (41(3)):374-377 doi:10.1080/01676830.2020.1867193.

    PMID: 33402004
  32. 32

    Long-term follow up of systemic rituximab therapy as first-line and salvage therapy for idiopathic orbital inflammation and review of the literature.

    Abou-Hanna JJ, Tiu Teo HM, Thangavel R, et al.

    Orbit (Amsterdam, Netherlands) 2022; (41(3)):297-304 doi:10.1080/01676830.2021.1874424.

    PMID: 33478316
  33. 33

    Masses of the Lacrimal Gland: Evaluation and Treatment.

    Kim JS, Liss J

    Journal of neurological surgery. Part B, Skull base 2021; (82(1)):100-106 doi:10.1055/s-0040-1722700.

    PMID: 33777623
  34. 34

    Conjunctival Infiltration in a Child as a Rare Manifestation of IgG4-Related Disease.

    Qi SR, Hébert M, You E, et al.

    Cornea 2022; (41(4)):496-498 doi:10.1097/ICO.0000000000002773.

    PMID: 34050069
  35. 35

    Clinical features and symptoms of IgG4-related ophthalmic disease: a multicenter study.

    Goto H, Ueda SI, Nemoto R, et al.

    Japanese journal of ophthalmology 2021; (65(5)):651-656 doi:10.1007/s10384-021-00847-3.

    PMID: 34146222
  36. 36

    Refractory Dry Eye Syndrome after Transconjunctival Excision of the Palpebral Lobe of the Lacrimal Gland.

    Lee YJ, Choi HS, Park SJ, et al.

    Medicina (Kaunas, Lithuania) 2021; (57(6)) doi:10.3390/medicina57060608.

    PMID: 34208279
  37. 37

    [Idiopathic orbital inflammation].

    Lieb WE

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; (118(8)):777-786 doi:10.1007/s00347-021-01459-5.

    PMID: 34324055
  38. 38

    Bilateral lacrimal gland lymphoma: Case report and literature review.

    Ngoc LB, Doan NV, Ngan VK, et al.

    Radiology case reports 2022; (17(1)):240-244 doi:10.1016/j.radcr.2021.10.046.

    PMID: 34840638
  39. 39

    Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.

    Gan L, Luo X, Fei Y, et al.

    BMC ophthalmology 2021; (21(1)):447 doi:10.1186/s12886-021-02210-z.

    PMID: 34961492
  40. 40

    Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort.

    Gan L, Luo X, Fei Y, et al.

    Frontiers in medicine 2021; (8()):784520 doi:10.3389/fmed.2021.784520.

    PMID: 34977087
  41. 41

    Clinical, Radiological and Histopathological Features of Patients With Lacrimal Gland Enlargement.

    Jamshidian Tehrani M, Asadi Khameneh E, Pourseyed Iazarjani SZ, et al.

    Archives of Iranian medicine 2021; (24(12)):910-915 doi:10.34172/aim.2021.136.

    PMID: 35014239
  42. 42

    Lacrimal Gland Lesions Biopsied in a Tertiary Eye Center in Saudi Arabia: A Clinical, Radiological, Surgical, and Histological Review.

    Alturkistany W, Althaqib R, Alsulaiman N, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2022; (16()):191-200 doi:10.2147/OPTH.S331252.

    PMID: 35115759
  43. 43

    Cases with IgG4-related ophthalmic disease with mass lesions surrounding the optic nerve.

    Hamaoka S, Takahira M, Kawano M, et al.

    American journal of ophthalmology case reports 2022; (25()):101324 doi:10.1016/j.ajoc.2022.101324.

    PMID: 35146198
  44. 44

    Pathological count of IgG4-positive plasmacytes suggests extraophthalmic involvement and relapse in patients with IgG4-related ophthalmic disease: a retrospective study.

    Yuan Y, Meng F, Ren H, et al.

    Arthritis research & therapy 2022; (24(1)):80 doi:10.1186/s13075-022-02757-2.

    PMID: 35365184
  45. 45

    Recurrent lacrimal gland pleomorphic adenoma.

    Reilly S, Ellard R, O'Sullivan M, et al.

    Orbit (Amsterdam, Netherlands) 2023; (42(6)):635-640 doi:10.1080/01676830.2022.2064515.

    PMID: 35546531
  46. 46

    A Rare Case of Neurosarcoidosis Overlapped with Sjogren's Syndrome.

    Cai W, Li R, He J, et al.

    Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195709.

    PMID: 36233588
  47. 47

    Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance.

    Chou WY, Tsai CY, Tsai CC

    Journal of personalized medicine 2022; (12(12)) doi:10.3390/jpm12121963.

    PMID: 36556184
  48. 48

    A case report: An unusual presentation of adenoid cystic carcinoma of the lacrimal gland.

    Liang M, Yu Z, Wang F

    Medicine 2023; (102(13)):e33446 doi:10.1097/MD.0000000000033446.

    PMID: 37000056
  49. 49

    Atypical presentation of bilateral Epstein-Barr virus dacryoadenitis: a case report of corticosteroid resistant orbital inflammation.

    Tan CH, Tauchi-Nishi PS, Sweeney AR

    Journal of ophthalmic inflammation and infection 2023; (13(1)):24 doi:10.1186/s12348-023-00349-y.

    PMID: 37173558
  50. 50

    Ocular Surface Evaluation in Immunoglobulin G4-Related Ophthalmic Disease.

    Lai KKH, Liao X, Aljufairi FMAA, et al.

    American journal of ophthalmology 2023; (256()):90-96 doi:10.1016/j.ajo.2023.07.031.

    PMID: 37544494
  51. 51

    Diagnostic Utility of Minor Salivary Gland Biopsy for Primary Sjögren Syndrome in Patients With Negative Anti-SSA Antibodies.

    Goel RR, Jeranko M, Jones L, et al.

    Cureus 2023; (15(9)):e46207 doi:10.7759/cureus.46207.

    PMID: 37905256
  52. 52

    Advances in imaging of the lacrimal gland in Sjögren's syndrome: A narrative review.

    Zhong W, Zhang H, Ran H

    Journal of clinical ultrasound : JCU 2024; (52(1)):68-77 doi:10.1002/jcu.23596.

    PMID: 37907965
  53. 53

    Systemic Involvement in Immunoglobulin G4-Related Ophthalmic Disease.

    Lai KKH, Aljufairi FMAA, Sebastian JU, et al.

    Ocular immunology and inflammation 2024; (32(8)):1852-1858 doi:10.1080/09273948.2023.2280709.

    PMID: 38055933
  54. 54

    Repeated Lacrimal Gland Biopsies.

    Kaushik M, Vahdani K, Neumann I, et al.

    Ophthalmic plastic and reconstructive surgery 2024; (40(4)):440-444 doi:10.1097/IOP.0000000000002614.

    PMID: 38329425
  55. 55

    Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.

    Zhong Q, Yan Y, Li S

    Medicine 2024; (103(21)):e38303 doi:10.1097/MD.0000000000038303.

    PMID: 38787969
  56. 56

    The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease.

    Takahira M, Goto H, Azumi A

    Japanese journal of ophthalmology 2024; (68(4)):293-301 doi:10.1007/s10384-024-01072-4.

    PMID: 39037515
  57. 57

    Assessing IgG4-related ophthalmic disease and its mimics: a comparison of ACR/EULAR, organ-specific and revised comprehensive diagnostic criteria.

    Bakshi N, Aggarwal A, Dhawan S, et al.

    Journal of clinical pathology 2025; (78(8)):554-561 doi:10.1136/jcp-2024-209552.

    PMID: 39160060
  58. 58

    Primary Ductal Her-2 Positive Adenocarcinoma of Salivary Gland: A Long Follow-Up Case Report and Review of the Literature.

    Deantoni CL, Midulla M, Mirabile A, et al.

    Case reports in ophthalmological medicine 2024; (2024()):4410206 doi:10.1155/2024/4410206.

    PMID: 39301249
  59. 59

    Magnetic resonance diffusion-weighted imaging in lacrimal gland lymphoma versus inflammation: A comparative study.

    Landau-Prat D, Shemesh R, Shalev D, et al.

    Indian journal of ophthalmology 2024; (72(10)):1448-1452 doi:10.4103/IJO.IJO_2109_23.

    PMID: 39331435
  60. 60

    Treatment of Idiopathic Inflammatory Orbital Syndrome (IOIS) With Prominent Lacrimal Gland Involvement Using Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

    Ling HM, Chow KM

    Cureus 2024; (16(8)):e67981 doi:10.7759/cureus.67981.

    PMID: 39347244
  61. 61

    The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis.

    Kanda M, Nagahata K, Moriyama M, et al.

    Modern rheumatology 2025; (35(3)):542-547 doi:10.1093/mr/roae096.

    PMID: 39441008
  62. 62

    Late onset paediatric dacryoadenitis associated with SARS-CoV-2 confirmed by histological analysis.

    Yokoyama K, Sato Y, Suimon Y, Kase S

    BMJ case reports 2024; (17(12)) doi:10.1136/bcr-2023-257615.

    PMID: 39694657
  63. 63

    Guidelines for the standardized diagnosis and treatment of non-specific orbital inflammation (2024).

    Shao Y, Ma JM, Yang HS,

    International journal of ophthalmology 2024; (17(12)):2203-2213 doi:10.18240/ijo.2024.12.07.

    PMID: 39697897
  64. 64

    Bilateral sequential bacterial dacryoadenitis with abscess- a case report.

    Lam L, Pietris J, Quigley C, et al.

    BMC ophthalmology 2025; (25(1)):227 doi:10.1186/s12886-025-04063-2.

    PMID: 40251557
  65. 65

    Idiopathic Posterior Scleritis Complicated by Optic Perineuritis and Ocular Motility Disorder Successfully Controlled with Adalimumab: A Case Report.

    Numaga Y, Aoyama Y, Tanaka R

    Case reports in ophthalmology 2025; (16(1)):916-925 doi:10.1159/000549539.

    PMID: 41404192
  66. 66

    Head and neck manifestations of IgG4-related disease: current understanding.

    Takano K

    Japanese journal of radiology 2026; (44(5)):856-865 doi:10.1007/s11604-025-01934-y.

    PMID: 41441946
  67. 67

    Gonococcal Dacryoadenitis: A Case Report.

    Hains L, Quigley C, Selva D

    Case reports in ophthalmology 2026; (17(1)):275-280 doi:10.1159/000550844.

    PMID: 41884366
  68. 68

    Management of IgG4-Related Disease.

    Hernández-Molina G, Anaya-Macías BU, Martín-Nares E

    Current rheumatology reports 2026; (28(1)).

    PMID: 42096015
  69. 69

    Atypical presentation of Epstein-Barr virus infectious mononucleosis with bilateral dacryoadenitis in an elderly patient: a case report.

    Mahfoud N, Ali M, Abboud M

    Journal of medical case reports 2026; (20(1)).

    PMID: 42192474
  70. 70

    The Lacrimal System.

    Kumar S, Kinde B, Pham N, Fischbein N

    Radiologic clinics of North America 2026; (64(4)):675-690 doi:10.1016/j.rcl.2026.02.006.

    PMID: 42230056
  71. 71

    Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland and impact on initial surgical planning.

    Esmaeli B, Lu T, Ketonen L, Debnam JM

    Frontiers in oncology 2026; (16()):1852743 doi:10.3389/fonc.2026.1852743.

    PMID: 42564044